Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA357253
Max Phase: Preclinical
Molecular Formula: C33H52N4O9S
Molecular Weight: 680.86
Molecule Type: Small molecule
Associated Items:
ID: ALA357253
Max Phase: Preclinical
Molecular Formula: C33H52N4O9S
Molecular Weight: 680.86
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)S(=O)(=O)CC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Standard InChI: InChI=1S/C33H52N4O9S/c1-33(2,3)47(45,46)19-23(14-21-10-6-4-7-11-21)31(43)37-26(16-24-17-34-20-35-24)32(44)36-25(15-22-12-8-5-9-13-22)28(40)30(42)29(41)27(39)18-38/h4,6-7,10-11,17,20,22-23,25-30,38-42H,5,8-9,12-16,18-19H2,1-3H3,(H,34,35)(H,36,44)(H,37,43)/t23?,25-,26?,27+,28+,29+,30+/m0/s1
Standard InChI Key: SEGJVTDZQVOHPV-BGYFKOBFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 680.86 | Molecular Weight (Monoisotopic): 680.3455 | AlogP: 0.40 | #Rotatable Bonds: 17 |
Polar Surface Area: 222.17 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.13 | CX Basic pKa: 6.53 | CX LogP: -0.02 | CX LogD: -0.08 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.11 | Np Likeness Score: 0.32 |
1. Kleemann HW, Heitsch H, Henning R, Kramer W, Kocher W, Lerch U, Linz W, Nickel WU, Ruppert D, Urbach H.. (1992) Renin inhibitory pentols showing improved enteral bioavailability., 35 (3): [PMID:1738148] [10.1021/jm00081a019] |
Source(1):